JENNIFER BURR: Open Payments
NPI 1528290988 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 20 payments from 10 companies in 2025. Trend: 2023 $835 · 2024 $343 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| HEARTFLOW, INC. | 3 | $66 |
| Novo Nordisk Inc | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| PFIZER INC. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: Attruby, JARDIANCE, FFRct, CAMZYOS, ELIQUIS, Ozempic, AMVUTTRA, NEXLETOL.
Industry payments across NY — which companies pay providers there.
